Beijing Hotgen Biotech Co., Ltd. Successfully Showcases at Medlab Asia & Asia Health 2025

From July 16–18, 2025, Hotgen Biotech made a triumphant appearance at the Medlab Asia & Asia Health exhibition held at MITEC in Kuala Lumpur, Malaysia (Booth R-01).

During the event, the company presented several market-acclaimed immunoassay solutions, including chemiluminescence (CLIA) and up-converting phosphor technology (UPT), featuring the Mono-Test CLIA series and the portable UPT2800 system. In addition, Hotgen unveiled two major innovations: the fully automated, compact chemiluminescence immunoassay analyzer C800, and a breakthrough small-molecule, dual-antibody sandwich immunoassay technology. The C800 delivers high throughput, compact design, and reliable stability to meet diverse laboratory needs, while the small-molecule dual-antibody method enables ultra-sensitive detection of trace targets.

This exhibition not only highlights Hotgen’s strong R&D capabilities in immunodiagnostics but also contributes to enhancing clinical laboratory testing capacity across Asia and worldwide.

For more detailed product information, please contact our official channel: sales@hotgen.com.cn